Wellgistics Q1 revenue $0.93M, net loss $7.7M; terminates Neuritek/WellCare LOIs; guides Q2 ~$1.78M

Wellgistics Health, Inc.

2026-Q1 EPS reported -$0.07 revenue$1,559,563

Revenue $0.93M in Q1 2026 vs $0.49M Q4 2025; expects Q2 rev $1.78M (with $0.86M recognized through May 18).
Net operating loss $7.74M vs $32.43M prior year; EPS -$0.07 vs -$0.62 on 104.6M shares.
Wellgistics Pharmacy monthly rev grew from ~$0.1M (Nov 2025) to ~$0.6M (Apr 2026).
Terminated non-binding LOIs with Neuritek and WellCare; advanced discussions with Datavault AI for HaaS expansion.
Partnership with Tollo Health and NFL Alumni Health; Health Lives Here app launch targeted Aug 2026.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Wellgistics Health, Inc. reported first quarter ended March 31, 2026 results: revenue $0.929 million, net income net operating loss of $7.742 million, EPS $0.07. Guidance initiated.

Period: first quarter ended March 31, 2026
Revenue: $0.929 million
Net income: net operating loss of $7.742 million
EPS: $0.07
Guidance: initiated
Result: reported results

Exact text from the filing

revenue opportunities,”noted Mr. Patel. First Quarter 2026 Corporate Highlights ● Sequential quarter over quarter revenue growth: ○ Q4-2025: $0.486 million ○ Q1-2026: $0.929 million ○ Q2-2026: The Company expects revenue of $1.775 million (projected, $0.86M already recognized through May 18, 2026) ● Added quantum key encryption functionality to the

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

Wellgistics Health, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-024454

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.